{"gene":"GABRG2","run_date":"2026-04-28T17:46:04","timeline":{"discoveries":[{"year":2016,"finding":"GABRG2 mutations reduce GABAA receptor channel function by diverse mechanisms including nonsense-mediated mRNA decay (NMD), endoplasmic reticulum-associated protein degradation (ERAD), dominant negative suppression of partnering subunits, mutant subunit aggregation causing cell stress and cell death, and gating defects. The γ2 subunit is critical for GABAA receptor trafficking and clustering at synapses; it oligomerizes with α and β subunits in the ER and only correctly assembled pentameric receptors traffic to the cell surface.","method":"Review synthesizing in vitro expression assays, patch clamp, immunoblotting, confocal imaging, mouse models","journal":"JAMA neurology","confidence":"High","confidence_rationale":"Tier 1–2 — synthesizes multiple orthogonal methods across many studies, replicated across labs","pmids":["27367160"],"is_preprint":false},{"year":2009,"finding":"The GABRG2 nonsense mutation Q351X produces a trafficking-deficient, ER-retained truncated γ2 subunit that exerts dominant-negative suppression of wild-type receptors: the mutant subunit oligomerizes with wild-type α1 and β2 subunits, traps them in the ER, subjects them to glycosylation arrest and ERAD via the ubiquitin-proteasome system, and reduces GABAA receptor surface expression and function beyond what simple haploinsufficiency would produce.","method":"Pulse-chase radiolabeling, co-immunoprecipitation, glycosylation assays, whole-cell patch clamp, immunoblotting in HEK293T cells","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal biochemical and electrophysiological methods in a single rigorous study","pmids":["19261880"],"is_preprint":false},{"year":2015,"finding":"In Gabrg2+/Q390X knock-in mice, the mutant γ2(Q390X) subunit accumulates and aggregates intracellularly in neurons, activates caspase-3, and causes widespread age-dependent neurodegeneration, demonstrating that the mutant subunit exerts toxicity beyond simple loss of GABAergic inhibition.","method":"Knock-in mouse model, immunohistochemistry, caspase-3 activation assay, behavioral analysis, EEG","journal":"Nature neuroscience","confidence":"High","confidence_rationale":"Tier 1–2 — in vivo knock-in model with multiple mechanistic readouts in a high-impact journal","pmids":["26005849"],"is_preprint":false},{"year":2012,"finding":"The intronic GABRG2 mutation IVS6+2T→G abolishes normal intron 6 splicing, activates a cryptic splice site causing partial intron retention and a frameshift that creates a premature stop codon. The resulting mutant mRNA is partially degraded by NMD; undegraded mRNA is translated to a stable truncated γ2-PTC subunit that is retained in the ER, oligomerizes with α1 and β2 subunits, and exerts a dominant-negative effect on αβγ2 receptor surface expression.","method":"BAC constructs expressed in HEK293T cells and transgenic mice, mRNA splicing analysis, immunoblotting, surface expression assays, electrophysiology","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1–2 — reconstitution in cells and transgenic mice with multiple orthogonal methods","pmids":["22539854"],"is_preprint":false},{"year":2013,"finding":"Different GABRG2 nonsense mutations produce truncated γ2 subunits with different degradation rates, stabilities, and levels of polyubiquitin conjugation; those in the last exon escape NMD and accumulate intracellularly, causing graded dominant-negative suppression of wild-type GABAA receptor biogenesis and function, and differential ER stress—mechanistically linking mutant subunit amount to epilepsy phenotypic severity.","method":"35S radiolabeling pulse-chase, flow cytometry, immunoblotting, immunohistochemistry, whole-cell patch clamp in non-neuronal cells and neurons, NMD minigene assay","journal":"Annals of neurology","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods with rigorous quantitative comparison across mutations","pmids":["23720301"],"is_preprint":false},{"year":2012,"finding":"The GABRG2 nonsense mutation Q40X activates NMD to degrade mutant γ2 mRNA; residual mRNA is translated to a truncated peptide (likely signal peptide) that is cleaved. The mutant subunit fails to assemble into functional GABAA receptors. Aminoglycoside-induced stop-codon read-through with gentamicin partially restored full-length γ2 subunit synthesis and rescued surface GABAA receptor expression and function.","method":"BAC constructs, NMD analysis, surface biotinylation, whole-cell patch clamp in HEK cells","journal":"Neurobiology of disease","confidence":"High","confidence_rationale":"Tier 1 — reconstitution with BAC constructs, in vitro assays, and pharmacological rescue","pmids":["22750526"],"is_preprint":false},{"year":2014,"finding":"Three GABRG2 missense mutations (R82Q, P83S, N79S) at the γ+/β− subunit interface disrupt GABAA receptor assembly to different extents: R82Q and P83S cause ER retention and degradation of unassembled subunits by impairing pentamer assembly, while N79S has minimal effect. Structural modeling predicted increased conformational variability at assembly motifs for R82Q and P83S. Lowering incubation temperature to 30°C partially rescued surface expression of mutant subunits by stabilizing receptor folding.","method":"Flow cytometry, immunoblotting, whole-cell patch clamp, structural modeling, temperature rescue experiment in HEK293T cells","journal":"Neurobiology of disease","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal biochemical and electrophysiological methods plus structural modeling","pmids":["24798517"],"is_preprint":false},{"year":2014,"finding":"The GABRG2 R177G febrile seizure mutation decreases GABAA receptor cell surface expression by causing ER retention and ERAD of mutant γ2L subunits. Wild-type γ2L subunits have a competitive advantage over R177G mutant subunits for receptor assembly/trafficking. Cycloheximide experiments showed the mutation primarily destabilizes unassembled γ2L subunits. Molecular modeling indicated disruption of intrasubunit salt bridges, destabilizing secondary and tertiary structure.","method":"Electrophysiology, flow cytometry, immunoblotting, cycloheximide chase, molecular modeling in HEK293T cells","journal":"Neurobiology of disease","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods with structural validation in a single study","pmids":["24874541"],"is_preprint":false},{"year":2014,"finding":"The GABRG2 R136* nonsense mutation produces γ2 subunits with reduced total and cell-surface expression that accumulate in intracellular aggregates surrounding the nucleus and ER, impairing receptor trafficking; co-expression with α1 and β2 subunits leads to reduced GABA-evoked currents.","method":"In vitro expression in HEK293T cells, flow cytometry, immunoblotting, whole-cell patch clamp, immunofluorescence","journal":"Neurobiology of disease","confidence":"Medium","confidence_rationale":"Tier 2 — multiple methods in a single lab study","pmids":["24407264"],"is_preprint":false},{"year":2016,"finding":"Different nonsense mutations in GABRG2 (R136*, Q390*, W429*) produce truncated γ2 subunits with different structural stabilities, surface hydrophobicities, and tendencies to dimerize, leading to differential suppression of wild-type partnering subunit surface expression and differentially reduced GABA-evoked current amplitudes—correlating with clinical epilepsy severity.","method":"Structural modeling, flow cytometry, immunoblotting, whole-cell patch clamp in HEK293T cells","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods in a single lab with structural modeling","pmids":["27762395"],"is_preprint":false},{"year":2016,"finding":"In de novo GABRG2 mutations associated with epileptic encephalopathy (A106T, I107T, P282S, R323W, F343L, R323Q), GABAA receptors containing mutant γ2 subunits show reduced cell surface expression with altered subunit stoichiometry or decreased GABA-evoked current amplitudes in HEK293T cells, with different levels of reduction for each mutation.","method":"Patch clamp recording, immunoblotting, confocal imaging, structural modelling in HEK293T cells","journal":"Brain","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods characterizing six distinct mutations in a single comprehensive study","pmids":["27864268"],"is_preprint":false},{"year":2016,"finding":"Comparing Gabrg2+/Q390X knock-in (KI) and Gabrg2+/- knockout (KO) mice showed that dominant-negative KI mice accumulate mutant γ2 subunits intracellularly in neurons, have reduced wild-type γ2 subunit expression in dendrites and synapses, and exhibit more severe seizures and behavioral comorbidities than KO haploinsufficient mice, which show no intracellular accumulation and unaffected wild-type subunit biogenesis.","method":"Western blot, immunohistochemistry, EEG, behavioral tests in knock-in vs. knockout mice","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 — direct comparison of two well-characterized mouse models with multiple readouts","pmids":["27340224"],"is_preprint":false},{"year":2012,"finding":"The GABRG2 frameshift mutation c.1329delC produces a stable mutant γ2S subunit with a modified elongated C-terminus that is retained in the ER and not expressed on the cell surface, resulting in haploinsufficiency; co-expression with α1 and β2 subunits produces currents comparable to α1β2 receptors lacking γ2 subunit, indicating loss of γ2 function.","method":"Immunoblotting, flow cytometry, whole-cell patch clamp in HEK293T cells","journal":"Neurobiology of disease","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods in a single study","pmids":["23069679"],"is_preprint":false},{"year":2014,"finding":"The GABRG2 Q40X mutation in dizygotic twins with Dravet syndrome causes reduced GABA-induced currents in reconstituted HEK cell receptors; microinjection of mutant γ2(Q40X) cDNA into HEK cells severely inhibited intracellular trafficking of GABAA receptor subunits α1 and β2, retaining them in the ER. In neurons, the mutant γ2 subunit also impairs axonal transport of α1 and β2 subunits.","method":"Electrophysiology in HEK cells, immunohistochemistry, microinjection, axonal transport analysis in neurons","journal":"Epilepsy research","confidence":"Medium","confidence_rationale":"Tier 2 — direct functional reconstitution plus neuronal axonal transport assay in a single study","pmids":["24480790"],"is_preprint":false},{"year":2011,"finding":"The GABRG2 K289M mutation accelerates receptor deactivation. Upon raising temperature, neurons expressing K289M mutant γ2 show increased lateral membrane diffusion of synaptic GABAA receptors (tracked by single-particle tracking), loss of receptor clusters, and reduced miniature inhibitory postsynaptic current frequency. This enhanced activity-dependent mobility during hyperthermia is blocked by glutamate receptor antagonists and mimicked by 4-aminopyridine, identifying altered membrane diffusion as a mechanism for temperature-sensitive epilepsy.","method":"Single-particle tracking, mIPSC electrophysiology, live imaging in neurons","journal":"Cerebral cortex","confidence":"High","confidence_rationale":"Tier 1–2 — single-particle tracking and electrophysiology with pharmacological dissection in neurons","pmids":["21908847"],"is_preprint":false},{"year":2017,"finding":"Overexpression of wild-type γ2 subunits via BAC transgene in Gabrg2+/Q390X knock-in mice increased wild-type γ2, α1, and β2/3 subunit expression, increased mIPSC amplitudes in cortical neurons, reduced thalamocortical network oscillations, and raised PTZ seizure threshold—demonstrating that seizures caused by dominant-negative γ2(Q390X) can be rescued by supplementing wild-type γ2 subunit.","method":"Transgenic cross, Western blot, immunohistochemistry, whole-cell patch clamp (mIPSC), EEG, PTZ seizure threshold testing in mice","journal":"Epilepsia","confidence":"High","confidence_rationale":"Tier 2 — in vivo genetic rescue with multiple mechanistic readouts","pmids":["28586508"],"is_preprint":false},{"year":2019,"finding":"In Gabrg2+/Q390X knock-in and Gabrg2+/- knockout mice, impaired GABAergic neurotransmission in the central nucleus of the amygdala (CeA)—but not basolateral amygdala—underlies comorbid anxiety, caused by reduced GABAA receptor subunit expression from the mutations. Chemogenetic activation or inactivation of inhibitory CeA neurons alone modulates anxiety-like behavior, and pharmacological enhancement of γ2-containing receptor signaling relieves anxiety.","method":"Brain slice electrophysiology, subcellular fractionation, Western blot, immunohistochemistry, confocal microscopy, behavioral tests, chemogenetics (DREADDs) in knock-in and knockout mice","journal":"Epilepsia","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods including chemogenetic circuit dissection and pharmacology in two mouse models","pmids":["31087664"],"is_preprint":false},{"year":2020,"finding":"In Gabrg2+/Q390X knock-in mice, proinflammatory cytokines (TNF-α, IL-1β, IL-6) are increased in multiple brain regions throughout development independent of seizure occurrence, driven by chronic mutant protein accumulation and ER stress. Pharmacological induction of ER stress upregulates cytokines in wild-type and KO but not in KI mice, and the mutant protein dampens cytokine induction upon further cellular stress.","method":"ELISA, immunoprecipitation, nuclei purification, immunoblot, immunohistochemistry, confocal microscopy in KI and KO mice and cultured neurons","journal":"Epilepsia","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal biochemical methods with direct comparison of two mouse models","pmids":["32944937"],"is_preprint":false},{"year":2016,"finding":"In Gabrg2+/Q390X knock-in mice associated with Dravet syndrome, synaptic GABAA receptors are reduced while intracellular non-functional γ2(Q390X) subunits are accumulated in brainstem nuclei (solitary tract, pre-Bötzinger complex, Kölliker-Fuse nuclei) controlling respiratory function, suggesting that impaired GABAergic transmission in these nuclei contributes to cardiorespiratory failure in SUDEP.","method":"Western blot, immunohistochemistry comparing KI and KO mice in specific brainstem nuclei","journal":"Epilepsy research","confidence":"Medium","confidence_rationale":"Tier 2 — regional quantification in two mouse models with anatomical specificity","pmids":["27131289"],"is_preprint":false},{"year":2021,"finding":"Neocortex- and hippocampus-specific conditional knockout of Gabrg2 in mice produces temperature-dependent myoclonic jerks, generalized tonic-clonic seizures, increased seizure susceptibility (to PTZ and hyperthermia), cortical hyperexcitability on EEG, and neuronal loss in cortical layers V–VI and hippocampus—establishing that loss of γ2 specifically in excitatory cortical and hippocampal neurons is sufficient to cause febrile seizure-like phenotypes.","method":"Cre/loxP conditional knockout, EEG, PTZ seizure threshold, behavioral tests, histology in mice","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 — clean conditional KO with defined electrophysiological and histological readouts","pmids":["34050134"],"is_preprint":false},{"year":2023,"finding":"4-Phenylbutyrate (PBA) reduces mutant γ2(Q390X) subunit protein aggregates, enhances trafficking of wild-type GABAA receptor subunits to the membrane in HEK293T cells and neurons, increases GABA-evoked current amplitudes, reduces ER stress, and mitigates seizures and EEG abnormalities in Gabrg2+/Q390X mice—acting not by directly modulating the mutant channel but by facilitating folding and transport of wild-type receptors.","method":"Biochemistry, differential allele tagging, live brain slice surface biotinylation, microsome isolation, patch-clamp, video-EEG in KI mice","journal":"Epilepsia","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal in vitro and in vivo methods with mechanistic specificity","pmids":["37746768"],"is_preprint":false},{"year":2024,"finding":"HRD1, an ER-associated E3 ubiquitin ligase, is identified as a strong modulator of wild-type and mutant γ2(Q390X) subunit expression; overexpressing or knocking down HRD1 dose-dependently reduces γ2(Q390X) subunit levels. Zonisamide, which upregulates HRD1, reduces seizures in Gabrg2 mice and partially rescues surface trafficking of GABAA receptors sequestered in the ER by the dominant-negative γ2(Q390X) subunit.","method":"Immunoprecipitation, Western blot, overexpression/knockdown of HRD1, ERAD pathway analysis, seizure monitoring in mice","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 2 — identifies specific E3 ligase with mechanistic follow-up and in vivo pharmacological validation","pmids":["38731820"],"is_preprint":false},{"year":2021,"finding":"Dravet syndrome-associated GABRG2 variants (T90R, P342L) primarily cause trafficking defects in GABAA receptor biogenesis (reduced surface expression), in contrast to GABRA1 and GABRB2 Dravet variants which express well at the surface but are functionally deficient (gating defects), suggesting subunit-specific mechanisms for the same disease phenotype.","method":"Patch clamp, immunoblotting, surface biotinylation, confocal microscopy in HEK293T cells","journal":"Brain communications","confidence":"Medium","confidence_rationale":"Tier 2 — multiple methods across multiple subunit comparisons in a single study","pmids":["34095830"],"is_preprint":false},{"year":2022,"finding":"GABRG2 variants associated with sleep-related hypermotor epilepsy (T90M and T317N) decrease GABA-evoked current amplitudes by diverse mechanisms: T90M causes impaired surface expression and ER retention; T317N causes channel gating defects. The Q217X variant reduces synaptic clustering and distribution of GABAA receptors.","method":"Electrophysiology, Western blot, flow cytometry, confocal microscopy in neuronal and non-neuronal cells","journal":"Journal of neurology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods in a single study","pmids":["35486215"],"is_preprint":false},{"year":2020,"finding":"Transgenic zebrafish overexpressing mutant human GABRG2(F343L) display spontaneous seizure-like behaviors, hyperactivity, and light-stimulation-induced seizures; they show upregulation of c-fos (a marker of epileptogenesis), altered GABAA receptor subunit expression, and upregulation of 33 genes associated with protein processing. HDAC inhibition with SAHA alleviates seizure-like phenotypes.","method":"Transgenic zebrafish model, RT-qPCR, in situ hybridization, automated locomotion tracking, RNA sequencing, pharmacological treatment","journal":"Annals of translational medicine","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo zebrafish model with transcriptomic and pharmacological validation","pmids":["33437759"],"is_preprint":false},{"year":2022,"finding":"Transgenic zebrafish overexpressing mutant GABRG2(F343L) display not only postsynaptic defects (altered GABAA receptor subunit expression) but also presynaptic defects in synaptic protein expression and synapse ultrastructure, expanding the mechanistic paradigm from channelopathy to synaptopathy for GABRG2-related epileptic encephalopathy.","method":"RT-qPCR, in situ hybridization, Western blot, synaptic protein immunostaining, electron microscopy in transgenic zebrafish","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 — multiple structural and molecular methods with functional behavioral correlation","pmids":["34957497"],"is_preprint":false},{"year":2025,"finding":"Functional assessment of 17 GABRG2 missense variants revealed that 9 cause loss-of-function (LoF), 3 cause gain-of-function (GoF), and 5 do not alter receptor function. GoF variants (e.g., A106T) are associated with the most severe phenotypes (DEE, early onset at 2 months, severe developmental impairment), while null LoF variants are associated with milder phenotypes than missense LoF variants, establishing that phenotypic severity depends on the functional consequence of the variant type.","method":"Electrophysiological recordings (patch clamp) of missense variants in recombinant receptors, clinical cohort analysis","journal":"Neurology","confidence":"High","confidence_rationale":"Tier 1–2 — systematic functional classification of 35 variants using electrophysiology correlated with clinical phenotypes in 44 individuals","pmids":["40570274"],"is_preprint":false},{"year":2025,"finding":"The recurrent GABRG2 p.A106T variant is a gain-of-function mutation confirmed by electrophysiological recordings. Structural homology modeling indicates the variant may enhance receptor gating by facilitating a hydrogen bond between the extracellular and transmembrane domains, a mechanism not observed with p.A106P (a functionally neutral variant at the same residue).","method":"Electrophysiological recordings, homology-based structural modeling","journal":"Epilepsia","confidence":"Medium","confidence_rationale":"Tier 1–2 — electrophysiology plus structural modeling, but single study","pmids":["41351427"],"is_preprint":false},{"year":2006,"finding":"A novel GABRG2 mutation associated with febrile seizures alters GABAA receptor current desensitization kinetics and reduces benzodiazepine enhancement of receptor currents, as demonstrated by electrophysiological studies of mutant receptors.","method":"Electrophysiology of recombinant mutant receptors","journal":"Neurology","confidence":"Medium","confidence_rationale":"Tier 1 — direct electrophysiological characterization, but single study, limited detail in abstract","pmids":["16924025"],"is_preprint":false},{"year":2025,"finding":"In Gabrg2+/A105T knock-in mice (modeling human A106T), γ2 subunit protein expression is selectively reduced in the hippocampus; mIPSC amplitudes are significantly decreased, indicating impaired synaptic GABAergic inhibition. Neuroinflammation (microglia activation, neuronal loss) precedes seizure onset, suggesting neuroinflammatory processes exacerbate epileptogenesis.","method":"Western blot, mIPSC electrophysiology, hippocampal transcriptome profiling, histology in knock-in mice","journal":"Cell death discovery","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo knock-in model with electrophysiology and transcriptomics, single study","pmids":["41053028"],"is_preprint":false}],"current_model":"GABRG2 encodes the γ2 subunit of GABAA receptors, which is essential for receptor assembly in the ER (oligomerizing with α and β subunits into functional pentamers), forward trafficking to the cell surface and synapses, and chloride channel gating; epilepsy-associated mutations reduce receptor function by diverse mechanisms—including NMD of mutant mRNA, ER retention and ERAD of misfolded subunits, dominant-negative trapping of wild-type partnering subunits via HRD1-mediated ubiquitin-proteasome degradation, intracellular aggregation causing ER stress, neuroinflammation, and neurodegeneration via caspase-3 activation—with phenotypic severity correlating with the degree of functional loss (null > missense loss-of-function) or gain-of-function, and with the specific mechanism (haploinsufficiency vs. dominant-negative toxicity)."},"narrative":{"teleology":[{"year":2006,"claim":"Early electrophysiology established that GABRG2 mutations associated with febrile seizures alter channel gating properties—specifically desensitization kinetics and benzodiazepine responsiveness—providing the first evidence that γ2 subunit variants cause epilepsy by changing receptor biophysics.","evidence":"Electrophysiology of recombinant mutant receptors in heterologous cells","pmids":["16924025"],"confidence":"Medium","gaps":["Single study with limited mechanistic detail","No trafficking or assembly analysis performed","In vivo relevance not tested"]},{"year":2009,"claim":"The Q351X nonsense mutation revealed that truncated γ2 subunits are not simply lost but actively oligomerize with wild-type α1 and β2 subunits, trap them in the ER via glycosylation arrest and ERAD, and suppress surface receptor expression beyond haploinsufficiency—establishing the dominant-negative paradigm for GABRG2 mutations.","evidence":"Pulse-chase radiolabeling, co-immunoprecipitation, glycosylation assays, whole-cell patch clamp in HEK293T cells","pmids":["19261880"],"confidence":"High","gaps":["Mechanism of selective ER retention not fully defined","In vivo validation pending at this point"]},{"year":2011,"claim":"Single-particle tracking of the K289M mutation demonstrated that γ2 subunit variants can alter lateral membrane dynamics of synaptic GABAA receptors in a temperature-dependent manner, providing a biophysical mechanism linking febrile seizure mutations to activity-dependent loss of synaptic inhibition.","evidence":"Single-particle tracking, mIPSC electrophysiology, pharmacological dissection in cultured neurons","pmids":["21908847"],"confidence":"High","gaps":["Whether enhanced diffusion is a general mechanism for other GABRG2 mutations unknown","No in vivo validation of membrane diffusion phenotype"]},{"year":2012,"claim":"Studies of multiple mutation types (intronic splice-site IVS6+2T→G, early nonsense Q40X, frameshift c.1329delC) established that GABRG2 mutations engage NMD, aberrant splicing, and ER retention in mutation-specific combinations, and that aminoglycoside read-through can partially rescue premature stop codon variants—demonstrating therapeutic tractability.","evidence":"BAC constructs in HEK cells and transgenic mice, NMD analysis, surface biotinylation, electrophysiology, flow cytometry","pmids":["22539854","22750526","23069679"],"confidence":"High","gaps":["Read-through efficiency in vivo not established","Relative contribution of NMD versus dominant-negative toxicity to disease severity unclear"]},{"year":2013,"claim":"Systematic comparison of multiple nonsense mutations revealed that truncated γ2 subunits in the last exon escape NMD and accumulate to cause graded dominant-negative suppression and differential ER stress, mechanistically linking mutant protein stability and abundance to epilepsy phenotypic severity.","evidence":"Pulse-chase, flow cytometry, immunohistochemistry, patch clamp, NMD minigene assay across multiple mutations","pmids":["23720301"],"confidence":"High","gaps":["Quantitative relationship between ER stress level and seizure severity not fully calibrated","Cell-type specificity of degradation pathways not addressed"]},{"year":2014,"claim":"Missense mutations at the γ+/β− subunit interface (R82Q, P83S) and in the extracellular domain (R177G) were shown to impair pentamer assembly and destabilize unassembled subunits, with temperature rescue at 30°C partially restoring surface expression—establishing that conformational instability during assembly is a major disease mechanism for GABRG2 missense variants.","evidence":"Flow cytometry, patch clamp, cycloheximide chase, structural modeling, temperature rescue in HEK293T cells","pmids":["24798517","24874541"],"confidence":"High","gaps":["No crystal or cryo-EM structure of mutant subunits","Temperature rescue not translatable to in vivo therapy"]},{"year":2015,"claim":"The Gabrg2+/Q390X knock-in mouse demonstrated that mutant γ2 subunit accumulation and aggregation in neurons activates caspase-3 and causes age-dependent neurodegeneration in vivo—establishing that dominant-negative GABRG2 mutations produce proteotoxicity beyond simple loss of inhibition.","evidence":"Knock-in mouse, immunohistochemistry, caspase-3 activation assay, behavioral analysis, EEG","pmids":["26005849"],"confidence":"High","gaps":["Specific aggregation-prone domains not mapped","Whether neurodegeneration is reversible upon aggregate clearance unknown"]},{"year":2016,"claim":"Direct comparison of knock-in (dominant-negative) versus knockout (haploinsufficiency) mice established that intracellular mutant protein accumulation, not merely reduced γ2 expression, drives more severe seizures, and comprehensive characterization of six de novo mutations confirmed that each variant reduces surface expression and/or channel function to different degrees correlating with clinical severity.","evidence":"KI vs. KO mouse comparison with Western blot, IHC, EEG, behavioral tests; patch clamp and confocal imaging of six mutations in HEK293T cells","pmids":["27340224","27864268","27762395"],"confidence":"High","gaps":["Cell-type-specific vulnerability to dominant-negative effects not mapped","Contribution of brainstem-specific receptor loss to SUDEP risk correlational"]},{"year":2017,"claim":"Genetic rescue via BAC-mediated wild-type γ2 overexpression in Gabrg2+/Q390X mice restored partnering subunit levels, increased mIPSC amplitudes, and raised seizure threshold—proving that supplementing wild-type γ2 can overcome dominant-negative suppression in vivo.","evidence":"Transgenic cross, Western blot, IHC, mIPSC recordings, EEG, PTZ seizure threshold in mice","pmids":["28586508"],"confidence":"High","gaps":["Optimal expression level for therapeutic benefit not defined","Whether gene therapy approaches can achieve sufficient γ2 expression in humans unknown"]},{"year":2019,"claim":"Circuit-level dissection revealed that impaired GABAergic inhibition specifically in central amygdala neurons underlies anxiety comorbidity in both KI and KO mice, with chemogenetic manipulation of these neurons bidirectionally modulating anxiety—linking GABRG2 loss to specific neural circuit dysfunction.","evidence":"Slice electrophysiology, subcellular fractionation, chemogenetics (DREADDs), behavioral tests in KI and KO mice","pmids":["31087664"],"confidence":"High","gaps":["Whether other comorbidities (cognitive, social) map to distinct circuits unknown","Human amygdala circuit involvement not confirmed"]},{"year":2020,"claim":"Chronic mutant γ2 protein accumulation was shown to drive neuroinflammation (elevated TNF-α, IL-1β, IL-6) throughout development independent of seizures, via sustained ER stress—adding neuroinflammation as a seizure-independent pathogenic mechanism and distinguishing KI from KO pathology.","evidence":"ELISA, immunoprecipitation, immunoblot in KI vs. KO mice and cultured neurons","pmids":["32944937"],"confidence":"High","gaps":["Whether anti-inflammatory therapy alone reduces seizure burden unknown","Specific ER stress sensors mediating cytokine induction not identified"]},{"year":2023,"claim":"4-Phenylbutyrate (PBA) was shown to reduce mutant γ2 aggregates, enhance wild-type receptor trafficking to the membrane, and mitigate seizures in KI mice—establishing pharmacological chaperoning as a viable therapeutic strategy that acts on wild-type receptor biogenesis rather than mutant channel correction.","evidence":"Differential allele tagging, live brain slice surface biotinylation, microsome isolation, patch-clamp, video-EEG in KI mice","pmids":["37746768"],"confidence":"High","gaps":["Long-term efficacy and safety of PBA in chronic treatment not assessed","Whether PBA acts on all GABRG2 mutation types unclear"]},{"year":2024,"claim":"Identification of HRD1 as the E3 ubiquitin ligase mediating ERAD of both wild-type and mutant γ2 subunits provided the first specific molecular component of the quality-control pathway, and pharmacological upregulation of HRD1 by zonisamide reduced seizures and partially rescued surface trafficking.","evidence":"IP, Western blot, HRD1 overexpression/knockdown, ERAD pathway analysis, seizure monitoring in mice","pmids":["38731820"],"confidence":"Medium","gaps":["Other E3 ligases or co-chaperones in the pathway not identified","Specificity of HRD1 for γ2 versus other GABAA subunits not determined","Single study requiring independent confirmation"]},{"year":2025,"claim":"Systematic functional classification of 17 missense variants revealed that gain-of-function variants (e.g., A106T) cause the most severe epileptic encephalopathies while null loss-of-function variants produce milder phenotypes, overturning the assumption that all pathogenic GABRG2 variants act through loss of function and establishing bidirectional functional change as a determinant of severity.","evidence":"Patch-clamp electrophysiology of recombinant receptors, clinical cohort of 44 individuals; knock-in mouse modeling of A106T with transcriptomics","pmids":["40570274","41351427","41053028"],"confidence":"High","gaps":["Structural basis of gain-of-function for A106T based on homology modeling only—cryo-EM structure needed","Whether GoF variants require different therapeutic strategies than LoF variants untested","Neuroinflammation preceding seizures in A106T KI mice requires mechanistic dissection"]},{"year":null,"claim":"Key unresolved questions include the structural basis of gain-of-function mutations at atomic resolution, whether targeting neuroinflammation or ER stress independently of receptor function can prevent epileptogenesis, and which specific neuronal populations are most vulnerable to dominant-negative proteotoxicity versus simple haploinsufficiency.","evidence":"","pmids":[],"confidence":"Low","gaps":["No cryo-EM or crystal structure of mutant γ2 subunit-containing receptors","Cell-type-specific vulnerability to proteotoxicity not mapped","Whether gene therapy or antisense strategies can selectively suppress mutant allele expression in vivo untested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[0,1,14,26,28]},{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[0,6,7]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,1,6,7,10,14]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[0,1,3,7,8,12]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[2,8]}],"pathway":[{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[0,14,16,19]},{"term_id":"R-HSA-9609507","term_label":"Protein localization","supporting_discovery_ids":[0,1,3,6,7,20]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[1,4,21]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[2,10,17,26]}],"complexes":["GABAA receptor (α1β2γ2 pentamer)"],"partners":["GABRA1","GABRB2","GABRB3","HRD1"],"other_free_text":[]},"mechanistic_narrative":"GABRG2 encodes the γ2 subunit of GABAA receptors, which is essential for receptor pentamer assembly in the endoplasmic reticulum, forward trafficking to the cell surface, synaptic clustering, and chloride channel gating that mediates fast inhibitory neurotransmission [PMID:27367160, PMID:19261880]. Epilepsy-associated GABRG2 mutations reduce receptor function through diverse mechanisms—including nonsense-mediated mRNA decay, ER retention and ERAD of misfolded subunits via HRD1-dependent ubiquitination, dominant-negative trapping of wild-type partnering subunits (α1, β2), intracellular aggregation causing ER stress and caspase-3-mediated neurodegeneration, and channel gating defects—with phenotypic severity correlating with the specific functional consequence of each variant [PMID:23720301, PMID:26005849, PMID:38731820, PMID:40570274]. Gain-of-function variants such as A106T, which enhance receptor gating, are associated with the most severe developmental and epileptic encephalopathies, while null loss-of-function alleles produce comparatively milder phenotypes than dominant-negative missense variants [PMID:40570274, PMID:41351427]. Mutant γ2 subunit accumulation drives chronic neuroinflammation and neurodegeneration independent of seizure activity, and supplementation of wild-type γ2 or pharmacological chaperones that promote proper folding rescue receptor biogenesis and seizure phenotypes in vivo [PMID:32944937, PMID:28586508, PMID:37746768]."},"prefetch_data":{"uniprot":{"accession":"P18507","full_name":"Gamma-aminobutyric acid receptor subunit gamma-2","aliases":["GABA(A) receptor subunit gamma-2","GABAAR subunit gamma-2"],"length_aa":475,"mass_kda":55.2,"function":"Gamma subunit of the heteropentameric ligand-gated chloride channel gated by gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the brain (PubMed:14993607, PubMed:16412217, PubMed:23909897, PubMed:2538761, PubMed:25489750, PubMed:27864268, PubMed:29950725, PubMed:30602789). GABA-gated chloride channels, also named GABA(A) receptors (GABAAR), consist of five subunits arranged around a central pore and contain GABA active binding site(s) located at the alpha and beta subunit interface(s) (PubMed:29950725, PubMed:30602789). When activated by GABA, GABAARs selectively allow the flow of chloride anions across the cell membrane down their electrochemical gradient (PubMed:14993607, PubMed:16412217, PubMed:2538761, PubMed:27864268, PubMed:29950725, PubMed:30602789). Gamma-2/GABRG2-containing GABAARs are found at both synaptic and extrasynaptic sites (By similarity). Chloride influx into the postsynaptic neuron following GABAAR opening decreases the neuron ability to generate a new action potential, thereby reducing nerve transmission (By similarity). GABAARs containing alpha-1 and beta-2 or -3 subunits exhibit synaptogenic activity; the gamma-2 subunit being necessary but not sufficient to induce rapid synaptic contacts formation (PubMed:23909897, PubMed:25489750). Extrasynaptic gamma-2-containing receptors contribute to the tonic GABAergic inhibition (By similarity). GABAARs function also as histamine receptor where histamine binds at the interface of two neighboring beta subunits and potentiates GABA response in a gamma-2 subunit-controlled manner (By similarity)","subcellular_location":"Postsynaptic cell membrane; Cell membrane; Cell projection, dendrite; Cytoplasmic vesicle membrane","url":"https://www.uniprot.org/uniprotkb/P18507/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GABRG2","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GABRG2","total_profiled":1310},"omim":[{"mim_id":"621120","title":"DELTA-LIKE NONCANONICAL NOTCH LIGAND 2; DLK2","url":"https://www.omim.org/entry/621120"},{"mim_id":"618396","title":"DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 74; DEE74","url":"https://www.omim.org/entry/618396"},{"mim_id":"607681","title":"FEBRILE SEIZURES, FAMILIAL, 8; FEB8","url":"https://www.omim.org/entry/607681"},{"mim_id":"607208","title":"DRAVET SYNDROME; DRVT","url":"https://www.omim.org/entry/607208"},{"mim_id":"605493","title":"TRIPARTITE MOTIF-CONTAINING PROTEIN 3; TRIM3","url":"https://www.omim.org/entry/605493"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"brain","ntpm":40.7},{"tissue":"retina","ntpm":10.3}],"url":"https://www.proteinatlas.org/search/GABRG2"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P18507","domains":[{"cath_id":"2.70.170.10","chopping":"62-270","consensus_level":"high","plddt":94.3393,"start":62,"end":270},{"cath_id":"1.20.58.390","chopping":"273-363_454-465","consensus_level":"high","plddt":92.6852,"start":273,"end":465}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P18507","model_url":"https://alphafold.ebi.ac.uk/files/AF-P18507-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P18507-F1-predicted_aligned_error_v6.png","plddt_mean":77.19},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GABRG2","jax_strain_url":"https://www.jax.org/strain/search?query=GABRG2"},"sequence":{"accession":"P18507","fasta_url":"https://rest.uniprot.org/uniprotkb/P18507.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P18507/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P18507"}},"corpus_meta":[{"pmid":"12117362","id":"PMC_12117362","title":"A splice-site mutation in GABRG2 associated with childhood absence epilepsy and febrile convulsions.","date":"2002","source":"Archives of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/12117362","citation_count":221,"is_preprint":false},{"pmid":"16924025","id":"PMC_16924025","title":"A novel GABRG2 mutation associated with febrile seizures.","date":"2006","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/16924025","citation_count":120,"is_preprint":false},{"pmid":"27367160","id":"PMC_27367160","title":"Molecular Pathogenic Basis for GABRG2 Mutations Associated With a Spectrum of Epilepsy Syndromes, From Generalized Absence Epilepsy to Dravet Syndrome.","date":"2016","source":"JAMA neurology","url":"https://pubmed.ncbi.nlm.nih.gov/27367160","citation_count":105,"is_preprint":false},{"pmid":"27864268","id":"PMC_27864268","title":"De novo GABRG2 mutations associated with epileptic encephalopathies.","date":"2016","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/27864268","citation_count":91,"is_preprint":false},{"pmid":"26005849","id":"PMC_26005849","title":"The human epilepsy mutation GABRG2(Q390X) causes chronic subunit accumulation and neurodegeneration.","date":"2015","source":"Nature neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/26005849","citation_count":80,"is_preprint":false},{"pmid":"19261880","id":"PMC_19261880","title":"The GABRG2 mutation, Q351X, associated with generalized epilepsy with febrile seizures plus, has both loss of function and dominant-negative suppression.","date":"2009","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/19261880","citation_count":79,"is_preprint":false},{"pmid":"35718920","id":"PMC_35718920","title":"Molecular and clinical descriptions of patients with GABAA receptor gene variants (GABRA1, GABRB2, GABRB3, GABRG2): A cohort study, review of literature, and genotype-phenotype correlation.","date":"2022","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/35718920","citation_count":67,"is_preprint":false},{"pmid":"18566737","id":"PMC_18566737","title":"SCN1A, SCN1B, and GABRG2 gene mutation analysis in Chinese families with generalized epilepsy with febrile seizures plus.","date":"2008","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18566737","citation_count":56,"is_preprint":false},{"pmid":"14738422","id":"PMC_14738422","title":"Generalized epilepsy with febrile seizures plus (GEFS+): clinical spectrum in seven Italian families unrelated to SCN1A, SCN1B, and GABRG2 gene mutations.","date":"2004","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/14738422","citation_count":49,"is_preprint":false},{"pmid":"27340224","id":"PMC_27340224","title":"Differential molecular and behavioural alterations in mouse models of GABRG2 haploinsufficiency versus dominant negative mutations associated with human epilepsy.","date":"2016","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27340224","citation_count":44,"is_preprint":false},{"pmid":"24061200","id":"PMC_24061200","title":"GABRG2, rs211037 is associated with epilepsy susceptibility, but not with antiepileptic drug resistance and febrile seizures.","date":"2013","source":"Pharmacogenetics and genomics","url":"https://pubmed.ncbi.nlm.nih.gov/24061200","citation_count":41,"is_preprint":false},{"pmid":"24798517","id":"PMC_24798517","title":"Three epilepsy-associated GABRG2 missense mutations at the γ+/β- interface disrupt GABAA receptor assembly and trafficking by similar mechanisms but to different extents.","date":"2014","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/24798517","citation_count":38,"is_preprint":false},{"pmid":"22750526","id":"PMC_22750526","title":"The GABRG2 nonsense mutation, Q40X, associated with Dravet syndrome activated NMD and generated a truncated subunit that was partially rescued by aminoglycoside-induced stop codon read-through.","date":"2012","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/22750526","citation_count":36,"is_preprint":false},{"pmid":"34095830","id":"PMC_34095830","title":"Dravet syndrome-associated mutations in GABRA1, GABRB2 and GABRG2 define the genetic landscape of defects of GABAA receptors.","date":"2021","source":"Brain communications","url":"https://pubmed.ncbi.nlm.nih.gov/34095830","citation_count":35,"is_preprint":false},{"pmid":"15772696","id":"PMC_15772696","title":"Haplotype association between GABAA receptor gamma2 subunit gene (GABRG2) and methamphetamine use disorder.","date":"2005","source":"The pharmacogenomics journal","url":"https://pubmed.ncbi.nlm.nih.gov/15772696","citation_count":35,"is_preprint":false},{"pmid":"24407264","id":"PMC_24407264","title":"A novel GABRG2 mutation, p.R136*, in a family with GEFS+ and extended phenotypes.","date":"2014","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/24407264","citation_count":34,"is_preprint":false},{"pmid":"23720301","id":"PMC_23720301","title":"Trafficking-deficient mutant GABRG2 subunit amount may modify epilepsy phenotype.","date":"2013","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/23720301","citation_count":34,"is_preprint":false},{"pmid":"24480790","id":"PMC_24480790","title":"Association of nonsense mutation in GABRG2 with abnormal trafficking of GABAA receptors in severe epilepsy.","date":"2014","source":"Epilepsy research","url":"https://pubmed.ncbi.nlm.nih.gov/24480790","citation_count":34,"is_preprint":false},{"pmid":"24874541","id":"PMC_24874541","title":"GABAA receptor biogenesis is impaired by the γ2 subunit febrile seizure-associated mutation, GABRG2(R177G).","date":"2014","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/24874541","citation_count":33,"is_preprint":false},{"pmid":"22539854","id":"PMC_22539854","title":"The intronic GABRG2 mutation, IVS6+2T->G, associated with childhood absence epilepsy altered subunit mRNA intron splicing, activated nonsense-mediated decay, and produced a stable truncated γ2 subunit.","date":"2012","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/22539854","citation_count":31,"is_preprint":false},{"pmid":"17162195","id":"PMC_17162195","title":"Association of GABRG2 polymorphisms with idiopathic generalized epilepsy.","date":"2007","source":"Pediatric neurology","url":"https://pubmed.ncbi.nlm.nih.gov/17162195","citation_count":31,"is_preprint":false},{"pmid":"21908847","id":"PMC_21908847","title":"A human mutation in Gabrg2 associated with generalized epilepsy alters the membrane dynamics of GABAA receptors.","date":"2011","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/21908847","citation_count":30,"is_preprint":false},{"pmid":"27066572","id":"PMC_27066572","title":"Novel GABRG2 mutations cause familial febrile seizures.","date":"2015","source":"Neurology. Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27066572","citation_count":28,"is_preprint":false},{"pmid":"22239287","id":"PMC_22239287","title":"Role of MDR1 C3435T and GABRG2 C588T gene polymorphisms in seizure occurrence and MDR1 effect on anti-epileptic drug (phenytoin) absorption.","date":"2012","source":"Genetic testing and molecular biomarkers","url":"https://pubmed.ncbi.nlm.nih.gov/22239287","citation_count":28,"is_preprint":false},{"pmid":"23069679","id":"PMC_23069679","title":"Impaired surface αβγ GABA(A) receptor expression in familial epilepsy due to a GABRG2 frameshift mutation.","date":"2012","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/23069679","citation_count":27,"is_preprint":false},{"pmid":"20485450","id":"PMC_20485450","title":"Mutational analysis of GABRG2 in a Japanese cohort with childhood epilepsies.","date":"2010","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20485450","citation_count":24,"is_preprint":false},{"pmid":"26452361","id":"PMC_26452361","title":"Contribution of GABRG2 Polymorphisms to Risk of Epilepsy and Febrile Seizure: a Multicenter Cohort Study and Meta-analysis.","date":"2015","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/26452361","citation_count":22,"is_preprint":false},{"pmid":"12759178","id":"PMC_12759178","title":"Failure to find causal mutations in the GABA(A)-receptor gamma2 subunit (GABRG2) gene in Japanese febrile seizure patients.","date":"2003","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/12759178","citation_count":22,"is_preprint":false},{"pmid":"28505490","id":"PMC_28505490","title":"Heat induced temperature dysregulation and seizures in Dravet Syndrome/GEFS+ Gabrg2+/Q390X mice.","date":"2017","source":"Epilepsy research","url":"https://pubmed.ncbi.nlm.nih.gov/28505490","citation_count":20,"is_preprint":false},{"pmid":"31004928","id":"PMC_31004928","title":"Novel variants and phenotypes widen the phenotypic spectrum of GABRG2-related disorders.","date":"2019","source":"Seizure","url":"https://pubmed.ncbi.nlm.nih.gov/31004928","citation_count":20,"is_preprint":false},{"pmid":"28586508","id":"PMC_28586508","title":"Overexpressing wild-type γ2 subunits rescued the seizure phenotype in Gabrg2+/Q390X Dravet syndrome mice.","date":"2017","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/28586508","citation_count":20,"is_preprint":false},{"pmid":"21983990","id":"PMC_21983990","title":"GABRG2 gene polymorphisms in Egyptian children with simple febrile seizures.","date":"2011","source":"Indian journal of pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/21983990","citation_count":20,"is_preprint":false},{"pmid":"15955415","id":"PMC_15955415","title":"Mutation screen of GABRA1, GABRB2 and GABRG2 genes in Japanese patients with absence seizures.","date":"2005","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/15955415","citation_count":17,"is_preprint":false},{"pmid":"36979350","id":"PMC_36979350","title":"GABRG2 Variants Associated with Febrile Seizures.","date":"2023","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/36979350","citation_count":17,"is_preprint":false},{"pmid":"23140995","id":"PMC_23140995","title":"GABRG2 rs211037 polymorphism and epilepsy: a systematic review and meta-analysis.","date":"2012","source":"Seizure","url":"https://pubmed.ncbi.nlm.nih.gov/23140995","citation_count":16,"is_preprint":false},{"pmid":"29379546","id":"PMC_29379546","title":"GABRG2 C588T gene polymorphisms might be a predictive genetic marker of febrile seizures and generalized recurrent seizures: a case-control study in a Romanian pediatric population.","date":"2016","source":"Archives of medical science : AMS","url":"https://pubmed.ncbi.nlm.nih.gov/29379546","citation_count":16,"is_preprint":false},{"pmid":"27762395","id":"PMC_27762395","title":"Differential protein structural disturbances and suppression of assembly partners produced by nonsense GABRG2 epilepsy mutations: implications for disease phenotypic heterogeneity.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27762395","citation_count":15,"is_preprint":false},{"pmid":"28460589","id":"PMC_28460589","title":"Expanding the phenotypic spectrum of GABRG2 variants: a recurrent GABRG2 missense variant associated with a severe phenotype.","date":"2017","source":"Journal of neurogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/28460589","citation_count":15,"is_preprint":false},{"pmid":"27131289","id":"PMC_27131289","title":"Altered GABAA receptor expression in brainstem nuclei and SUDEP in Gabrg2(+/Q390X) mice associated with epileptic encephalopathy.","date":"2016","source":"Epilepsy research","url":"https://pubmed.ncbi.nlm.nih.gov/27131289","citation_count":15,"is_preprint":false},{"pmid":"23287319","id":"PMC_23287319","title":"Lack of association between rs211037 of the GABRG2 gene and juvenile myoclonic epilepsy in Brazilian population.","date":"2012","source":"Neurology India","url":"https://pubmed.ncbi.nlm.nih.gov/23287319","citation_count":14,"is_preprint":false},{"pmid":"12694927","id":"PMC_12694927","title":"No evidence of GABRG2 mutations in severe myoclonic epilepsy of infancy.","date":"2003","source":"Epilepsy research","url":"https://pubmed.ncbi.nlm.nih.gov/12694927","citation_count":14,"is_preprint":false},{"pmid":"33437759","id":"PMC_33437759","title":"The GABRG2 F343L allele causes spontaneous seizures in a novel transgenic zebrafish model that can be treated with suberanilohydroxamic acid (SAHA).","date":"2020","source":"Annals of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33437759","citation_count":14,"is_preprint":false},{"pmid":"34050134","id":"PMC_34050134","title":"Neocortex- and hippocampus-specific deletion of Gabrg2 causes temperature-dependent seizures in mice.","date":"2021","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/34050134","citation_count":12,"is_preprint":false},{"pmid":"31087664","id":"PMC_31087664","title":"Molecular basis for and chemogenetic modulation of comorbidities in GABRG2-deficient epilepsies.","date":"2019","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/31087664","citation_count":12,"is_preprint":false},{"pmid":"31022638","id":"PMC_31022638","title":"The therapeutic effect of stiripentol in Gabrg2+/Q390X mice associated with epileptic encephalopathy.","date":"2019","source":"Epilepsy research","url":"https://pubmed.ncbi.nlm.nih.gov/31022638","citation_count":12,"is_preprint":false},{"pmid":"24776921","id":"PMC_24776921","title":"Association study of GABRG2 polymorphisms with suicidal behaviour in schizophrenia patients with alcohol use disorder.","date":"2014","source":"Neuropsychobiology","url":"https://pubmed.ncbi.nlm.nih.gov/24776921","citation_count":12,"is_preprint":false},{"pmid":"32944937","id":"PMC_32944937","title":"Endoplasmic reticulum stress increases inflammatory cytokines in an epilepsy mouse model Gabrg2+/Q390X knockin: A link between genetic and acquired epilepsy?","date":"2020","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/32944937","citation_count":12,"is_preprint":false},{"pmid":"16256272","id":"PMC_16256272","title":"Mutations in GABRA1, GABRA5, GABRG2 and GABRD receptor genes are not a major factor in the pathogenesis of familial focal epilepsy preceded by febrile seizures.","date":"2005","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/16256272","citation_count":12,"is_preprint":false},{"pmid":"32056912","id":"PMC_32056912","title":"Interactions of the GABRG2 polymorphisms and childhood trauma on suicide attempt and related traits in depressed patients.","date":"2020","source":"Journal of affective disorders","url":"https://pubmed.ncbi.nlm.nih.gov/32056912","citation_count":11,"is_preprint":false},{"pmid":"32418750","id":"PMC_32418750","title":"GABRG2 Deletion Linked to Genetic Epilepsy with Febrile Seizures Plus Affects the Expression of GABAA Receptor Subunits and Other Genes at Different Temperatures.","date":"2020","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/32418750","citation_count":11,"is_preprint":false},{"pmid":"25573302","id":"PMC_25573302","title":"Variants in SELL, MRPS36P2, TP63, DDB2, CACNA1H, ADAM19, GNAI1, CDH13 and GABRG2 interact to confer risk of acne in Chinese population.","date":"2015","source":"The Journal of dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/25573302","citation_count":10,"is_preprint":false},{"pmid":"33650258","id":"PMC_33650258","title":"Analysis of GABRG2 C588T polymorphism in genetic epilepsy and evaluation of GABRG2 in drug treatment.","date":"2021","source":"Clinical and translational science","url":"https://pubmed.ncbi.nlm.nih.gov/33650258","citation_count":9,"is_preprint":false},{"pmid":"35486215","id":"PMC_35486215","title":"Rare variants in GABRG2 associated with sleep-related hypermotor epilepsy.","date":"2022","source":"Journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/35486215","citation_count":9,"is_preprint":false},{"pmid":"34957497","id":"PMC_34957497","title":"An epileptic encephalopathy associated GABRG2 missense mutation leads to pre- and postsynaptic defects in zebrafish.","date":"2022","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/34957497","citation_count":8,"is_preprint":false},{"pmid":"34552348","id":"PMC_34552348","title":"Genetic Polymorphism of GABRG2 rs211037 is Associated with Drug Response and Adverse Drug Reactions to Valproic Acid in Chinese Southern Children with Epilepsy.","date":"2021","source":"Pharmacogenomics and personalized medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34552348","citation_count":8,"is_preprint":false},{"pmid":"22572707","id":"PMC_22572707","title":"Investigation of the role of the GABRG2 gene variant in migraine.","date":"2012","source":"Journal of the neurological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/22572707","citation_count":8,"is_preprint":false},{"pmid":"37746768","id":"PMC_37746768","title":"4-Phenylbutyrate promoted wild-type γ-aminobutyric acid type A receptor trafficking, reduced endoplasmic reticulum stress, and mitigated seizures in Gabrg2+/Q390X mice associated with Dravet syndrome.","date":"2023","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/37746768","citation_count":7,"is_preprint":false},{"pmid":"27871023","id":"PMC_27871023","title":"Association of a novel GABRG2 splicing variation and a PTGS2/COX-2 single nucleotide polymorphism with Taiwanese febrile seizures.","date":"2016","source":"Epilepsy research","url":"https://pubmed.ncbi.nlm.nih.gov/27871023","citation_count":7,"is_preprint":false},{"pmid":"39143639","id":"PMC_39143639","title":"GABRG2 mutations in genetic epilepsy with febrile seizures plus: structure, roles, and molecular genetics.","date":"2024","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/39143639","citation_count":6,"is_preprint":false},{"pmid":"40570274","id":"PMC_40570274","title":"Phenotypic Spectrum in Individuals With Pathogenic GABRG2 Loss- and Gain-of-Function Variants.","date":"2025","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/40570274","citation_count":6,"is_preprint":false},{"pmid":"31321301","id":"PMC_31321301","title":"Human GABRG2 generalized epilepsy: Increased somatosensory and striatothalamic connectivity.","date":"2019","source":"Neurology. Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31321301","citation_count":6,"is_preprint":false},{"pmid":"27293336","id":"PMC_27293336","title":"Mutations in GABRG2 receptor gene are not a major factor in the pathogenesis of mesial temporal lobe epilepsy in Indian population.","date":"2016","source":"Annals of Indian Academy of Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/27293336","citation_count":6,"is_preprint":false},{"pmid":"38731820","id":"PMC_38731820","title":"Modulating Endoplasmic Reticulum Chaperones and Mutant Protein Degradation in GABRG2(Q390X) Associated with Genetic Epilepsy with Febrile Seizures Plus and Dravet Syndrome.","date":"2024","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38731820","citation_count":6,"is_preprint":false},{"pmid":"36425336","id":"PMC_36425336","title":"GABRG2 C588T Polymorphism Is Associated with Idiopathic Generalized Epilepsy but Not with Antiepileptic Drug Resistance in Pakistani Cohort.","date":"2022","source":"BioMed research international","url":"https://pubmed.ncbi.nlm.nih.gov/36425336","citation_count":6,"is_preprint":false},{"pmid":"37703949","id":"PMC_37703949","title":"Epilepsy plus blindness in microdeletion of GABRA1 and GABRG2 in mouse and human.","date":"2023","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/37703949","citation_count":5,"is_preprint":false},{"pmid":"39053637","id":"PMC_39053637","title":"Preliminary study on the mechanism of SAHA in the treatment of refractory epilepsy induced by GABRG2(F343L) mutation.","date":"2024","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/39053637","citation_count":5,"is_preprint":false},{"pmid":"27889765","id":"PMC_27889765","title":"Contribution of Common Variants in GABRG2, RELN and NRG3 and Interaction Networks to the Risk of Hirschsprung Disease.","date":"2016","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/27889765","citation_count":5,"is_preprint":false},{"pmid":"38357846","id":"PMC_38357846","title":"Differential inflammation responses determine the variable phenotypes of epilepsy induced by GABRG2 mutations.","date":"2024","source":"CNS neuroscience & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/38357846","citation_count":5,"is_preprint":false},{"pmid":"20098824","id":"PMC_20098824","title":"The GABA(A)-receptor γ2 (GABRG2) gene in obsessive-compulsive disorder.","date":"2009","source":"Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)","url":"https://pubmed.ncbi.nlm.nih.gov/20098824","citation_count":5,"is_preprint":false},{"pmid":"37536979","id":"PMC_37536979","title":"Precision medicine: Vinpocetine as a potential treatment for GABRG2-related epilepsy.","date":"2023","source":"Epileptic disorders : international epilepsy journal with videotape","url":"https://pubmed.ncbi.nlm.nih.gov/37536979","citation_count":5,"is_preprint":false},{"pmid":"34080406","id":"PMC_34080406","title":"Association of rs211037 GABRG2 gene polymorphism with susceptibility to idiopathic generalized epilepsy.","date":"2021","source":"Medicinski glasnik : official publication of the Medical Association of Zenica-Doboj Canton, Bosnia and Herzegovina","url":"https://pubmed.ncbi.nlm.nih.gov/34080406","citation_count":4,"is_preprint":false},{"pmid":"34557020","id":"PMC_34557020","title":"The Effects of Gene Variations of GABRA2, GABRB1, GABRG2, GAD1 and SLC1A3 on Patients with Propofol During Anesthesia Induction.","date":"2021","source":"Pharmacogenomics and personalized medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34557020","citation_count":4,"is_preprint":false},{"pmid":"35377129","id":"PMC_35377129","title":"Electroacupuncture at PC6 (Neiguan) Attenuates Angina Pectoris in Rats with Myocardial Ischemia-Reperfusion Injury Through Regulating the Alternative Splicing of the Major Inhibitory Neurotransmitter Receptor GABRG2.","date":"2022","source":"Journal of cardiovascular translational research","url":"https://pubmed.ncbi.nlm.nih.gov/35377129","citation_count":4,"is_preprint":false},{"pmid":"39052185","id":"PMC_39052185","title":"Repetitive Transcranial Magnetic Stimulation-Mediated Neuroprotection in the 5xFAD Mouse Model of Alzheimer's Disease Through GABRG2 and SNAP25 Modulation.","date":"2024","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/39052185","citation_count":4,"is_preprint":false},{"pmid":"18175077","id":"PMC_18175077","title":"GEFS+ is not related to the most common mutations of SCN1B, SCN1A and GABRG2 in two Tunisian families.","date":"2008","source":"Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/18175077","citation_count":4,"is_preprint":false},{"pmid":"40000820","id":"PMC_40000820","title":"Insight into molecular and mutational scrutiny of epilepsy associated gene Gabrg2 leading to novel computer-aided drug designing.","date":"2025","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/40000820","citation_count":3,"is_preprint":false},{"pmid":"37632399","id":"PMC_37632399","title":"A novel GABRG2 variant in Sunflower syndrome: A case report and video EEG monitoring.","date":"2023","source":"Epileptic disorders : international epilepsy journal with videotape","url":"https://pubmed.ncbi.nlm.nih.gov/37632399","citation_count":2,"is_preprint":false},{"pmid":"19065515","id":"PMC_19065515","title":"[Analysis of the GABRG2 gene mutation in a Chinese family with generalized epilepsy with febrile seizures plus].","date":"2008","source":"Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19065515","citation_count":2,"is_preprint":false},{"pmid":"29929832","id":"PMC_29929832","title":"Mutational screening of GABRG2 gene in Pakistani population of Punjab with generalized tonic clonic seizures and children with childhood absence epilepsy.","date":"2018","source":"Journal of the Chinese Medical Association : JCMA","url":"https://pubmed.ncbi.nlm.nih.gov/29929832","citation_count":2,"is_preprint":false},{"pmid":"40849687","id":"PMC_40849687","title":"The Functional Interplay among GAD2, GABRG2, and CACNA1G Genes in Cancers.","date":"2025","source":"Asian Pacific journal of cancer prevention : APJCP","url":"https://pubmed.ncbi.nlm.nih.gov/40849687","citation_count":1,"is_preprint":false},{"pmid":"41053028","id":"PMC_41053028","title":"A knock-in mouse model for GABRG2-related epileptic encephalopathy displays spontaneous generalized seizures and cognitive impairment.","date":"2025","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/41053028","citation_count":1,"is_preprint":false},{"pmid":"11328646","id":"PMC_11328646","title":"Complete genomic sequence of 195 Kb of human DNA containing the gene GABRG2.","date":"2000","source":"DNA sequence : the journal of DNA sequencing and mapping","url":"https://pubmed.ncbi.nlm.nih.gov/11328646","citation_count":1,"is_preprint":false},{"pmid":"41146305","id":"PMC_41146305","title":"Association of GABRG2 gene polymorphisms with idiopathic generalized epilepsy in Egyptian children: a case-control study.","date":"2025","source":"European journal of medical research","url":"https://pubmed.ncbi.nlm.nih.gov/41146305","citation_count":1,"is_preprint":false},{"pmid":"38176934","id":"PMC_38176934","title":"Association between GABRG2 Gene Single Nucleotide Polymorphisms and Susceptibility to Ischemic Stroke in a Chinese Population.","date":"2023","source":"Journal of integrative neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/38176934","citation_count":0,"is_preprint":false},{"pmid":"41351427","id":"PMC_41351427","title":"Early neurological symptoms and epilepsy outcomes in individuals with the recurrent GABRG2 p.(Ala106Thr) gain-of-function variant: Structural and phenotypic insights.","date":"2025","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/41351427","citation_count":0,"is_preprint":false},{"pmid":"41193790","id":"PMC_41193790","title":"Beyond Impaired GABAergic Signaling: Inflammation and Metabolic Dysfunction in Genetic Epilepsy Induced by GABRG2 Mutation.","date":"2025","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/41193790","citation_count":0,"is_preprint":false},{"pmid":"36221407","id":"PMC_36221407","title":"The likelihood approach for potential role of \"GABRG2 (C588T, C315T) gene polymorphisms\" on the poor response to carbamazepine therapy in Pakhtun population of Pakistan.","date":"2022","source":"Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/36221407","citation_count":0,"is_preprint":false},{"pmid":"39297975","id":"PMC_39297975","title":"Genetic predisposition of suicidal behavior: variants in GRIN2B, GABRG2, and ODC1 genes in attempted and completed suicide in two Balkan populations.","date":"2024","source":"European archives of psychiatry and clinical neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/39297975","citation_count":0,"is_preprint":false},{"pmid":"40811894","id":"PMC_40811894","title":"Phenotypic variation in a family with GABRG2-related epilepsy caused by a novel missense variant.","date":"2025","source":"Seizure","url":"https://pubmed.ncbi.nlm.nih.gov/40811894","citation_count":0,"is_preprint":false},{"pmid":"41537003","id":"PMC_41537003","title":"Increased excitability of layer 5 neocortical pyramidal neurons and its contribution to seizure activity in Gabrg2 gene-deficient mice.","date":"2025","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/41537003","citation_count":0,"is_preprint":false},{"pmid":"41031595","id":"PMC_41031595","title":"Mass Spectrometry Imaging Reveals the Distribution of a GABRG2 Targeting Antisense Oligonucleotide and Its Functional Effect in Rat Brain.","date":"2025","source":"ACS chemical neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/41031595","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.11.24.690161","title":"Sex and experience dependent regulation of synaptic protein turnover","date":"2025-11-25","source":"bioRxiv","url":"https://doi.org/10.1101/2025.11.24.690161","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.12.30.24319794","title":"Gene-Burden Meta-Analysis of 748,879 Individuals Identifies LGI1-ADAM23 Protein Complex Association with Epilepsy","date":"2024-12-31","source":"bioRxiv","url":"https://doi.org/10.1101/2024.12.30.24319794","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":50986,"output_tokens":7410,"usd":0.132054},"stage2":{"model":"claude-opus-4-6","input_tokens":11311,"output_tokens":3805,"usd":0.22752},"total_usd":0.359574,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2016,\n      \"finding\": \"GABRG2 mutations reduce GABAA receptor channel function by diverse mechanisms including nonsense-mediated mRNA decay (NMD), endoplasmic reticulum-associated protein degradation (ERAD), dominant negative suppression of partnering subunits, mutant subunit aggregation causing cell stress and cell death, and gating defects. The γ2 subunit is critical for GABAA receptor trafficking and clustering at synapses; it oligomerizes with α and β subunits in the ER and only correctly assembled pentameric receptors traffic to the cell surface.\",\n      \"method\": \"Review synthesizing in vitro expression assays, patch clamp, immunoblotting, confocal imaging, mouse models\",\n      \"journal\": \"JAMA neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — synthesizes multiple orthogonal methods across many studies, replicated across labs\",\n      \"pmids\": [\"27367160\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"The GABRG2 nonsense mutation Q351X produces a trafficking-deficient, ER-retained truncated γ2 subunit that exerts dominant-negative suppression of wild-type receptors: the mutant subunit oligomerizes with wild-type α1 and β2 subunits, traps them in the ER, subjects them to glycosylation arrest and ERAD via the ubiquitin-proteasome system, and reduces GABAA receptor surface expression and function beyond what simple haploinsufficiency would produce.\",\n      \"method\": \"Pulse-chase radiolabeling, co-immunoprecipitation, glycosylation assays, whole-cell patch clamp, immunoblotting in HEK293T cells\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal biochemical and electrophysiological methods in a single rigorous study\",\n      \"pmids\": [\"19261880\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"In Gabrg2+/Q390X knock-in mice, the mutant γ2(Q390X) subunit accumulates and aggregates intracellularly in neurons, activates caspase-3, and causes widespread age-dependent neurodegeneration, demonstrating that the mutant subunit exerts toxicity beyond simple loss of GABAergic inhibition.\",\n      \"method\": \"Knock-in mouse model, immunohistochemistry, caspase-3 activation assay, behavioral analysis, EEG\",\n      \"journal\": \"Nature neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vivo knock-in model with multiple mechanistic readouts in a high-impact journal\",\n      \"pmids\": [\"26005849\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The intronic GABRG2 mutation IVS6+2T→G abolishes normal intron 6 splicing, activates a cryptic splice site causing partial intron retention and a frameshift that creates a premature stop codon. The resulting mutant mRNA is partially degraded by NMD; undegraded mRNA is translated to a stable truncated γ2-PTC subunit that is retained in the ER, oligomerizes with α1 and β2 subunits, and exerts a dominant-negative effect on αβγ2 receptor surface expression.\",\n      \"method\": \"BAC constructs expressed in HEK293T cells and transgenic mice, mRNA splicing analysis, immunoblotting, surface expression assays, electrophysiology\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — reconstitution in cells and transgenic mice with multiple orthogonal methods\",\n      \"pmids\": [\"22539854\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Different GABRG2 nonsense mutations produce truncated γ2 subunits with different degradation rates, stabilities, and levels of polyubiquitin conjugation; those in the last exon escape NMD and accumulate intracellularly, causing graded dominant-negative suppression of wild-type GABAA receptor biogenesis and function, and differential ER stress—mechanistically linking mutant subunit amount to epilepsy phenotypic severity.\",\n      \"method\": \"35S radiolabeling pulse-chase, flow cytometry, immunoblotting, immunohistochemistry, whole-cell patch clamp in non-neuronal cells and neurons, NMD minigene assay\",\n      \"journal\": \"Annals of neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods with rigorous quantitative comparison across mutations\",\n      \"pmids\": [\"23720301\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The GABRG2 nonsense mutation Q40X activates NMD to degrade mutant γ2 mRNA; residual mRNA is translated to a truncated peptide (likely signal peptide) that is cleaved. The mutant subunit fails to assemble into functional GABAA receptors. Aminoglycoside-induced stop-codon read-through with gentamicin partially restored full-length γ2 subunit synthesis and rescued surface GABAA receptor expression and function.\",\n      \"method\": \"BAC constructs, NMD analysis, surface biotinylation, whole-cell patch clamp in HEK cells\",\n      \"journal\": \"Neurobiology of disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution with BAC constructs, in vitro assays, and pharmacological rescue\",\n      \"pmids\": [\"22750526\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Three GABRG2 missense mutations (R82Q, P83S, N79S) at the γ+/β− subunit interface disrupt GABAA receptor assembly to different extents: R82Q and P83S cause ER retention and degradation of unassembled subunits by impairing pentamer assembly, while N79S has minimal effect. Structural modeling predicted increased conformational variability at assembly motifs for R82Q and P83S. Lowering incubation temperature to 30°C partially rescued surface expression of mutant subunits by stabilizing receptor folding.\",\n      \"method\": \"Flow cytometry, immunoblotting, whole-cell patch clamp, structural modeling, temperature rescue experiment in HEK293T cells\",\n      \"journal\": \"Neurobiology of disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal biochemical and electrophysiological methods plus structural modeling\",\n      \"pmids\": [\"24798517\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"The GABRG2 R177G febrile seizure mutation decreases GABAA receptor cell surface expression by causing ER retention and ERAD of mutant γ2L subunits. Wild-type γ2L subunits have a competitive advantage over R177G mutant subunits for receptor assembly/trafficking. Cycloheximide experiments showed the mutation primarily destabilizes unassembled γ2L subunits. Molecular modeling indicated disruption of intrasubunit salt bridges, destabilizing secondary and tertiary structure.\",\n      \"method\": \"Electrophysiology, flow cytometry, immunoblotting, cycloheximide chase, molecular modeling in HEK293T cells\",\n      \"journal\": \"Neurobiology of disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods with structural validation in a single study\",\n      \"pmids\": [\"24874541\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"The GABRG2 R136* nonsense mutation produces γ2 subunits with reduced total and cell-surface expression that accumulate in intracellular aggregates surrounding the nucleus and ER, impairing receptor trafficking; co-expression with α1 and β2 subunits leads to reduced GABA-evoked currents.\",\n      \"method\": \"In vitro expression in HEK293T cells, flow cytometry, immunoblotting, whole-cell patch clamp, immunofluorescence\",\n      \"journal\": \"Neurobiology of disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple methods in a single lab study\",\n      \"pmids\": [\"24407264\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Different nonsense mutations in GABRG2 (R136*, Q390*, W429*) produce truncated γ2 subunits with different structural stabilities, surface hydrophobicities, and tendencies to dimerize, leading to differential suppression of wild-type partnering subunit surface expression and differentially reduced GABA-evoked current amplitudes—correlating with clinical epilepsy severity.\",\n      \"method\": \"Structural modeling, flow cytometry, immunoblotting, whole-cell patch clamp in HEK293T cells\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods in a single lab with structural modeling\",\n      \"pmids\": [\"27762395\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"In de novo GABRG2 mutations associated with epileptic encephalopathy (A106T, I107T, P282S, R323W, F343L, R323Q), GABAA receptors containing mutant γ2 subunits show reduced cell surface expression with altered subunit stoichiometry or decreased GABA-evoked current amplitudes in HEK293T cells, with different levels of reduction for each mutation.\",\n      \"method\": \"Patch clamp recording, immunoblotting, confocal imaging, structural modelling in HEK293T cells\",\n      \"journal\": \"Brain\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods characterizing six distinct mutations in a single comprehensive study\",\n      \"pmids\": [\"27864268\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Comparing Gabrg2+/Q390X knock-in (KI) and Gabrg2+/- knockout (KO) mice showed that dominant-negative KI mice accumulate mutant γ2 subunits intracellularly in neurons, have reduced wild-type γ2 subunit expression in dendrites and synapses, and exhibit more severe seizures and behavioral comorbidities than KO haploinsufficient mice, which show no intracellular accumulation and unaffected wild-type subunit biogenesis.\",\n      \"method\": \"Western blot, immunohistochemistry, EEG, behavioral tests in knock-in vs. knockout mice\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct comparison of two well-characterized mouse models with multiple readouts\",\n      \"pmids\": [\"27340224\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The GABRG2 frameshift mutation c.1329delC produces a stable mutant γ2S subunit with a modified elongated C-terminus that is retained in the ER and not expressed on the cell surface, resulting in haploinsufficiency; co-expression with α1 and β2 subunits produces currents comparable to α1β2 receptors lacking γ2 subunit, indicating loss of γ2 function.\",\n      \"method\": \"Immunoblotting, flow cytometry, whole-cell patch clamp in HEK293T cells\",\n      \"journal\": \"Neurobiology of disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods in a single study\",\n      \"pmids\": [\"23069679\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"The GABRG2 Q40X mutation in dizygotic twins with Dravet syndrome causes reduced GABA-induced currents in reconstituted HEK cell receptors; microinjection of mutant γ2(Q40X) cDNA into HEK cells severely inhibited intracellular trafficking of GABAA receptor subunits α1 and β2, retaining them in the ER. In neurons, the mutant γ2 subunit also impairs axonal transport of α1 and β2 subunits.\",\n      \"method\": \"Electrophysiology in HEK cells, immunohistochemistry, microinjection, axonal transport analysis in neurons\",\n      \"journal\": \"Epilepsy research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct functional reconstitution plus neuronal axonal transport assay in a single study\",\n      \"pmids\": [\"24480790\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"The GABRG2 K289M mutation accelerates receptor deactivation. Upon raising temperature, neurons expressing K289M mutant γ2 show increased lateral membrane diffusion of synaptic GABAA receptors (tracked by single-particle tracking), loss of receptor clusters, and reduced miniature inhibitory postsynaptic current frequency. This enhanced activity-dependent mobility during hyperthermia is blocked by glutamate receptor antagonists and mimicked by 4-aminopyridine, identifying altered membrane diffusion as a mechanism for temperature-sensitive epilepsy.\",\n      \"method\": \"Single-particle tracking, mIPSC electrophysiology, live imaging in neurons\",\n      \"journal\": \"Cerebral cortex\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — single-particle tracking and electrophysiology with pharmacological dissection in neurons\",\n      \"pmids\": [\"21908847\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Overexpression of wild-type γ2 subunits via BAC transgene in Gabrg2+/Q390X knock-in mice increased wild-type γ2, α1, and β2/3 subunit expression, increased mIPSC amplitudes in cortical neurons, reduced thalamocortical network oscillations, and raised PTZ seizure threshold—demonstrating that seizures caused by dominant-negative γ2(Q390X) can be rescued by supplementing wild-type γ2 subunit.\",\n      \"method\": \"Transgenic cross, Western blot, immunohistochemistry, whole-cell patch clamp (mIPSC), EEG, PTZ seizure threshold testing in mice\",\n      \"journal\": \"Epilepsia\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic rescue with multiple mechanistic readouts\",\n      \"pmids\": [\"28586508\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"In Gabrg2+/Q390X knock-in and Gabrg2+/- knockout mice, impaired GABAergic neurotransmission in the central nucleus of the amygdala (CeA)—but not basolateral amygdala—underlies comorbid anxiety, caused by reduced GABAA receptor subunit expression from the mutations. Chemogenetic activation or inactivation of inhibitory CeA neurons alone modulates anxiety-like behavior, and pharmacological enhancement of γ2-containing receptor signaling relieves anxiety.\",\n      \"method\": \"Brain slice electrophysiology, subcellular fractionation, Western blot, immunohistochemistry, confocal microscopy, behavioral tests, chemogenetics (DREADDs) in knock-in and knockout mice\",\n      \"journal\": \"Epilepsia\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including chemogenetic circuit dissection and pharmacology in two mouse models\",\n      \"pmids\": [\"31087664\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"In Gabrg2+/Q390X knock-in mice, proinflammatory cytokines (TNF-α, IL-1β, IL-6) are increased in multiple brain regions throughout development independent of seizure occurrence, driven by chronic mutant protein accumulation and ER stress. Pharmacological induction of ER stress upregulates cytokines in wild-type and KO but not in KI mice, and the mutant protein dampens cytokine induction upon further cellular stress.\",\n      \"method\": \"ELISA, immunoprecipitation, nuclei purification, immunoblot, immunohistochemistry, confocal microscopy in KI and KO mice and cultured neurons\",\n      \"journal\": \"Epilepsia\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal biochemical methods with direct comparison of two mouse models\",\n      \"pmids\": [\"32944937\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"In Gabrg2+/Q390X knock-in mice associated with Dravet syndrome, synaptic GABAA receptors are reduced while intracellular non-functional γ2(Q390X) subunits are accumulated in brainstem nuclei (solitary tract, pre-Bötzinger complex, Kölliker-Fuse nuclei) controlling respiratory function, suggesting that impaired GABAergic transmission in these nuclei contributes to cardiorespiratory failure in SUDEP.\",\n      \"method\": \"Western blot, immunohistochemistry comparing KI and KO mice in specific brainstem nuclei\",\n      \"journal\": \"Epilepsy research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — regional quantification in two mouse models with anatomical specificity\",\n      \"pmids\": [\"27131289\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Neocortex- and hippocampus-specific conditional knockout of Gabrg2 in mice produces temperature-dependent myoclonic jerks, generalized tonic-clonic seizures, increased seizure susceptibility (to PTZ and hyperthermia), cortical hyperexcitability on EEG, and neuronal loss in cortical layers V–VI and hippocampus—establishing that loss of γ2 specifically in excitatory cortical and hippocampal neurons is sufficient to cause febrile seizure-like phenotypes.\",\n      \"method\": \"Cre/loxP conditional knockout, EEG, PTZ seizure threshold, behavioral tests, histology in mice\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean conditional KO with defined electrophysiological and histological readouts\",\n      \"pmids\": [\"34050134\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"4-Phenylbutyrate (PBA) reduces mutant γ2(Q390X) subunit protein aggregates, enhances trafficking of wild-type GABAA receptor subunits to the membrane in HEK293T cells and neurons, increases GABA-evoked current amplitudes, reduces ER stress, and mitigates seizures and EEG abnormalities in Gabrg2+/Q390X mice—acting not by directly modulating the mutant channel but by facilitating folding and transport of wild-type receptors.\",\n      \"method\": \"Biochemistry, differential allele tagging, live brain slice surface biotinylation, microsome isolation, patch-clamp, video-EEG in KI mice\",\n      \"journal\": \"Epilepsia\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal in vitro and in vivo methods with mechanistic specificity\",\n      \"pmids\": [\"37746768\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"HRD1, an ER-associated E3 ubiquitin ligase, is identified as a strong modulator of wild-type and mutant γ2(Q390X) subunit expression; overexpressing or knocking down HRD1 dose-dependently reduces γ2(Q390X) subunit levels. Zonisamide, which upregulates HRD1, reduces seizures in Gabrg2 mice and partially rescues surface trafficking of GABAA receptors sequestered in the ER by the dominant-negative γ2(Q390X) subunit.\",\n      \"method\": \"Immunoprecipitation, Western blot, overexpression/knockdown of HRD1, ERAD pathway analysis, seizure monitoring in mice\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — identifies specific E3 ligase with mechanistic follow-up and in vivo pharmacological validation\",\n      \"pmids\": [\"38731820\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Dravet syndrome-associated GABRG2 variants (T90R, P342L) primarily cause trafficking defects in GABAA receptor biogenesis (reduced surface expression), in contrast to GABRA1 and GABRB2 Dravet variants which express well at the surface but are functionally deficient (gating defects), suggesting subunit-specific mechanisms for the same disease phenotype.\",\n      \"method\": \"Patch clamp, immunoblotting, surface biotinylation, confocal microscopy in HEK293T cells\",\n      \"journal\": \"Brain communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple methods across multiple subunit comparisons in a single study\",\n      \"pmids\": [\"34095830\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"GABRG2 variants associated with sleep-related hypermotor epilepsy (T90M and T317N) decrease GABA-evoked current amplitudes by diverse mechanisms: T90M causes impaired surface expression and ER retention; T317N causes channel gating defects. The Q217X variant reduces synaptic clustering and distribution of GABAA receptors.\",\n      \"method\": \"Electrophysiology, Western blot, flow cytometry, confocal microscopy in neuronal and non-neuronal cells\",\n      \"journal\": \"Journal of neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods in a single study\",\n      \"pmids\": [\"35486215\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Transgenic zebrafish overexpressing mutant human GABRG2(F343L) display spontaneous seizure-like behaviors, hyperactivity, and light-stimulation-induced seizures; they show upregulation of c-fos (a marker of epileptogenesis), altered GABAA receptor subunit expression, and upregulation of 33 genes associated with protein processing. HDAC inhibition with SAHA alleviates seizure-like phenotypes.\",\n      \"method\": \"Transgenic zebrafish model, RT-qPCR, in situ hybridization, automated locomotion tracking, RNA sequencing, pharmacological treatment\",\n      \"journal\": \"Annals of translational medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo zebrafish model with transcriptomic and pharmacological validation\",\n      \"pmids\": [\"33437759\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Transgenic zebrafish overexpressing mutant GABRG2(F343L) display not only postsynaptic defects (altered GABAA receptor subunit expression) but also presynaptic defects in synaptic protein expression and synapse ultrastructure, expanding the mechanistic paradigm from channelopathy to synaptopathy for GABRG2-related epileptic encephalopathy.\",\n      \"method\": \"RT-qPCR, in situ hybridization, Western blot, synaptic protein immunostaining, electron microscopy in transgenic zebrafish\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple structural and molecular methods with functional behavioral correlation\",\n      \"pmids\": [\"34957497\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Functional assessment of 17 GABRG2 missense variants revealed that 9 cause loss-of-function (LoF), 3 cause gain-of-function (GoF), and 5 do not alter receptor function. GoF variants (e.g., A106T) are associated with the most severe phenotypes (DEE, early onset at 2 months, severe developmental impairment), while null LoF variants are associated with milder phenotypes than missense LoF variants, establishing that phenotypic severity depends on the functional consequence of the variant type.\",\n      \"method\": \"Electrophysiological recordings (patch clamp) of missense variants in recombinant receptors, clinical cohort analysis\",\n      \"journal\": \"Neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — systematic functional classification of 35 variants using electrophysiology correlated with clinical phenotypes in 44 individuals\",\n      \"pmids\": [\"40570274\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"The recurrent GABRG2 p.A106T variant is a gain-of-function mutation confirmed by electrophysiological recordings. Structural homology modeling indicates the variant may enhance receptor gating by facilitating a hydrogen bond between the extracellular and transmembrane domains, a mechanism not observed with p.A106P (a functionally neutral variant at the same residue).\",\n      \"method\": \"Electrophysiological recordings, homology-based structural modeling\",\n      \"journal\": \"Epilepsia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 — electrophysiology plus structural modeling, but single study\",\n      \"pmids\": [\"41351427\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"A novel GABRG2 mutation associated with febrile seizures alters GABAA receptor current desensitization kinetics and reduces benzodiazepine enhancement of receptor currents, as demonstrated by electrophysiological studies of mutant receptors.\",\n      \"method\": \"Electrophysiology of recombinant mutant receptors\",\n      \"journal\": \"Neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — direct electrophysiological characterization, but single study, limited detail in abstract\",\n      \"pmids\": [\"16924025\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"In Gabrg2+/A105T knock-in mice (modeling human A106T), γ2 subunit protein expression is selectively reduced in the hippocampus; mIPSC amplitudes are significantly decreased, indicating impaired synaptic GABAergic inhibition. Neuroinflammation (microglia activation, neuronal loss) precedes seizure onset, suggesting neuroinflammatory processes exacerbate epileptogenesis.\",\n      \"method\": \"Western blot, mIPSC electrophysiology, hippocampal transcriptome profiling, histology in knock-in mice\",\n      \"journal\": \"Cell death discovery\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo knock-in model with electrophysiology and transcriptomics, single study\",\n      \"pmids\": [\"41053028\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GABRG2 encodes the γ2 subunit of GABAA receptors, which is essential for receptor assembly in the ER (oligomerizing with α and β subunits into functional pentamers), forward trafficking to the cell surface and synapses, and chloride channel gating; epilepsy-associated mutations reduce receptor function by diverse mechanisms—including NMD of mutant mRNA, ER retention and ERAD of misfolded subunits, dominant-negative trapping of wild-type partnering subunits via HRD1-mediated ubiquitin-proteasome degradation, intracellular aggregation causing ER stress, neuroinflammation, and neurodegeneration via caspase-3 activation—with phenotypic severity correlating with the degree of functional loss (null > missense loss-of-function) or gain-of-function, and with the specific mechanism (haploinsufficiency vs. dominant-negative toxicity).\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"GABRG2 encodes the γ2 subunit of GABAA receptors, which is essential for receptor pentamer assembly in the endoplasmic reticulum, forward trafficking to the cell surface, synaptic clustering, and chloride channel gating that mediates fast inhibitory neurotransmission [PMID:27367160, PMID:19261880]. Epilepsy-associated GABRG2 mutations reduce receptor function through diverse mechanisms—including nonsense-mediated mRNA decay, ER retention and ERAD of misfolded subunits via HRD1-dependent ubiquitination, dominant-negative trapping of wild-type partnering subunits (α1, β2), intracellular aggregation causing ER stress and caspase-3-mediated neurodegeneration, and channel gating defects—with phenotypic severity correlating with the specific functional consequence of each variant [PMID:23720301, PMID:26005849, PMID:38731820, PMID:40570274]. Gain-of-function variants such as A106T, which enhance receptor gating, are associated with the most severe developmental and epileptic encephalopathies, while null loss-of-function alleles produce comparatively milder phenotypes than dominant-negative missense variants [PMID:40570274, PMID:41351427]. Mutant γ2 subunit accumulation drives chronic neuroinflammation and neurodegeneration independent of seizure activity, and supplementation of wild-type γ2 or pharmacological chaperones that promote proper folding rescue receptor biogenesis and seizure phenotypes in vivo [PMID:32944937, PMID:28586508, PMID:37746768].\",\n  \"teleology\": [\n    {\n      \"year\": 2006,\n      \"claim\": \"Early electrophysiology established that GABRG2 mutations associated with febrile seizures alter channel gating properties—specifically desensitization kinetics and benzodiazepine responsiveness—providing the first evidence that γ2 subunit variants cause epilepsy by changing receptor biophysics.\",\n      \"evidence\": \"Electrophysiology of recombinant mutant receptors in heterologous cells\",\n      \"pmids\": [\"16924025\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single study with limited mechanistic detail\", \"No trafficking or assembly analysis performed\", \"In vivo relevance not tested\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"The Q351X nonsense mutation revealed that truncated γ2 subunits are not simply lost but actively oligomerize with wild-type α1 and β2 subunits, trap them in the ER via glycosylation arrest and ERAD, and suppress surface receptor expression beyond haploinsufficiency—establishing the dominant-negative paradigm for GABRG2 mutations.\",\n      \"evidence\": \"Pulse-chase radiolabeling, co-immunoprecipitation, glycosylation assays, whole-cell patch clamp in HEK293T cells\",\n      \"pmids\": [\"19261880\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of selective ER retention not fully defined\", \"In vivo validation pending at this point\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Single-particle tracking of the K289M mutation demonstrated that γ2 subunit variants can alter lateral membrane dynamics of synaptic GABAA receptors in a temperature-dependent manner, providing a biophysical mechanism linking febrile seizure mutations to activity-dependent loss of synaptic inhibition.\",\n      \"evidence\": \"Single-particle tracking, mIPSC electrophysiology, pharmacological dissection in cultured neurons\",\n      \"pmids\": [\"21908847\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether enhanced diffusion is a general mechanism for other GABRG2 mutations unknown\", \"No in vivo validation of membrane diffusion phenotype\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Studies of multiple mutation types (intronic splice-site IVS6+2T→G, early nonsense Q40X, frameshift c.1329delC) established that GABRG2 mutations engage NMD, aberrant splicing, and ER retention in mutation-specific combinations, and that aminoglycoside read-through can partially rescue premature stop codon variants—demonstrating therapeutic tractability.\",\n      \"evidence\": \"BAC constructs in HEK cells and transgenic mice, NMD analysis, surface biotinylation, electrophysiology, flow cytometry\",\n      \"pmids\": [\"22539854\", \"22750526\", \"23069679\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Read-through efficiency in vivo not established\", \"Relative contribution of NMD versus dominant-negative toxicity to disease severity unclear\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Systematic comparison of multiple nonsense mutations revealed that truncated γ2 subunits in the last exon escape NMD and accumulate to cause graded dominant-negative suppression and differential ER stress, mechanistically linking mutant protein stability and abundance to epilepsy phenotypic severity.\",\n      \"evidence\": \"Pulse-chase, flow cytometry, immunohistochemistry, patch clamp, NMD minigene assay across multiple mutations\",\n      \"pmids\": [\"23720301\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Quantitative relationship between ER stress level and seizure severity not fully calibrated\", \"Cell-type specificity of degradation pathways not addressed\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Missense mutations at the γ+/β− subunit interface (R82Q, P83S) and in the extracellular domain (R177G) were shown to impair pentamer assembly and destabilize unassembled subunits, with temperature rescue at 30°C partially restoring surface expression—establishing that conformational instability during assembly is a major disease mechanism for GABRG2 missense variants.\",\n      \"evidence\": \"Flow cytometry, patch clamp, cycloheximide chase, structural modeling, temperature rescue in HEK293T cells\",\n      \"pmids\": [\"24798517\", \"24874541\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No crystal or cryo-EM structure of mutant subunits\", \"Temperature rescue not translatable to in vivo therapy\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"The Gabrg2+/Q390X knock-in mouse demonstrated that mutant γ2 subunit accumulation and aggregation in neurons activates caspase-3 and causes age-dependent neurodegeneration in vivo—establishing that dominant-negative GABRG2 mutations produce proteotoxicity beyond simple loss of inhibition.\",\n      \"evidence\": \"Knock-in mouse, immunohistochemistry, caspase-3 activation assay, behavioral analysis, EEG\",\n      \"pmids\": [\"26005849\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific aggregation-prone domains not mapped\", \"Whether neurodegeneration is reversible upon aggregate clearance unknown\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Direct comparison of knock-in (dominant-negative) versus knockout (haploinsufficiency) mice established that intracellular mutant protein accumulation, not merely reduced γ2 expression, drives more severe seizures, and comprehensive characterization of six de novo mutations confirmed that each variant reduces surface expression and/or channel function to different degrees correlating with clinical severity.\",\n      \"evidence\": \"KI vs. KO mouse comparison with Western blot, IHC, EEG, behavioral tests; patch clamp and confocal imaging of six mutations in HEK293T cells\",\n      \"pmids\": [\"27340224\", \"27864268\", \"27762395\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cell-type-specific vulnerability to dominant-negative effects not mapped\", \"Contribution of brainstem-specific receptor loss to SUDEP risk correlational\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Genetic rescue via BAC-mediated wild-type γ2 overexpression in Gabrg2+/Q390X mice restored partnering subunit levels, increased mIPSC amplitudes, and raised seizure threshold—proving that supplementing wild-type γ2 can overcome dominant-negative suppression in vivo.\",\n      \"evidence\": \"Transgenic cross, Western blot, IHC, mIPSC recordings, EEG, PTZ seizure threshold in mice\",\n      \"pmids\": [\"28586508\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Optimal expression level for therapeutic benefit not defined\", \"Whether gene therapy approaches can achieve sufficient γ2 expression in humans unknown\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Circuit-level dissection revealed that impaired GABAergic inhibition specifically in central amygdala neurons underlies anxiety comorbidity in both KI and KO mice, with chemogenetic manipulation of these neurons bidirectionally modulating anxiety—linking GABRG2 loss to specific neural circuit dysfunction.\",\n      \"evidence\": \"Slice electrophysiology, subcellular fractionation, chemogenetics (DREADDs), behavioral tests in KI and KO mice\",\n      \"pmids\": [\"31087664\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether other comorbidities (cognitive, social) map to distinct circuits unknown\", \"Human amygdala circuit involvement not confirmed\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Chronic mutant γ2 protein accumulation was shown to drive neuroinflammation (elevated TNF-α, IL-1β, IL-6) throughout development independent of seizures, via sustained ER stress—adding neuroinflammation as a seizure-independent pathogenic mechanism and distinguishing KI from KO pathology.\",\n      \"evidence\": \"ELISA, immunoprecipitation, immunoblot in KI vs. KO mice and cultured neurons\",\n      \"pmids\": [\"32944937\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether anti-inflammatory therapy alone reduces seizure burden unknown\", \"Specific ER stress sensors mediating cytokine induction not identified\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"4-Phenylbutyrate (PBA) was shown to reduce mutant γ2 aggregates, enhance wild-type receptor trafficking to the membrane, and mitigate seizures in KI mice—establishing pharmacological chaperoning as a viable therapeutic strategy that acts on wild-type receptor biogenesis rather than mutant channel correction.\",\n      \"evidence\": \"Differential allele tagging, live brain slice surface biotinylation, microsome isolation, patch-clamp, video-EEG in KI mice\",\n      \"pmids\": [\"37746768\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Long-term efficacy and safety of PBA in chronic treatment not assessed\", \"Whether PBA acts on all GABRG2 mutation types unclear\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identification of HRD1 as the E3 ubiquitin ligase mediating ERAD of both wild-type and mutant γ2 subunits provided the first specific molecular component of the quality-control pathway, and pharmacological upregulation of HRD1 by zonisamide reduced seizures and partially rescued surface trafficking.\",\n      \"evidence\": \"IP, Western blot, HRD1 overexpression/knockdown, ERAD pathway analysis, seizure monitoring in mice\",\n      \"pmids\": [\"38731820\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Other E3 ligases or co-chaperones in the pathway not identified\", \"Specificity of HRD1 for γ2 versus other GABAA subunits not determined\", \"Single study requiring independent confirmation\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Systematic functional classification of 17 missense variants revealed that gain-of-function variants (e.g., A106T) cause the most severe epileptic encephalopathies while null loss-of-function variants produce milder phenotypes, overturning the assumption that all pathogenic GABRG2 variants act through loss of function and establishing bidirectional functional change as a determinant of severity.\",\n      \"evidence\": \"Patch-clamp electrophysiology of recombinant receptors, clinical cohort of 44 individuals; knock-in mouse modeling of A106T with transcriptomics\",\n      \"pmids\": [\"40570274\", \"41351427\", \"41053028\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of gain-of-function for A106T based on homology modeling only—cryo-EM structure needed\", \"Whether GoF variants require different therapeutic strategies than LoF variants untested\", \"Neuroinflammation preceding seizures in A106T KI mice requires mechanistic dissection\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis of gain-of-function mutations at atomic resolution, whether targeting neuroinflammation or ER stress independently of receptor function can prevent epileptogenesis, and which specific neuronal populations are most vulnerable to dominant-negative proteotoxicity versus simple haploinsufficiency.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No cryo-EM or crystal structure of mutant γ2 subunit-containing receptors\", \"Cell-type-specific vulnerability to proteotoxicity not mapped\", \"Whether gene therapy or antisense strategies can selectively suppress mutant allele expression in vivo untested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 1, 14, 26, 28]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [0, 6, 7]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 1, 6, 7, 10, 14]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [0, 1, 3, 7, 8, 12]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [2, 8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [0, 14, 16, 19]},\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [0, 1, 3, 6, 7, 20]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [1, 4, 21]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [2, 10, 17, 26]}\n    ],\n    \"complexes\": [\n      \"GABAA receptor (α1β2γ2 pentamer)\"\n    ],\n    \"partners\": [\n      \"GABRA1\",\n      \"GABRB2\",\n      \"GABRB3\",\n      \"HRD1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}